V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 220013629 | 220008056 | 1.65 | 97 | Disease modification (D) | 2013-07-18 | 2013-08-25 | AML18 PILOT TRIAL | null | N | 220030712 | PILOT TRIAL |
| 220013630 | 220008058 | 1.78 | 79 | Curative (C) | 2017-09-07 | 2017-09-19 | Alemtuz+Fludara+Melphalan RIC MUD | null | Y | 220030713 | ALEMTUZUMAB + FLUDARABINE + MELPHALAN |
| 220013631 | 220008061 | 1.65 | null | null | 2015-11-12 | 2015-11-13 | Rituximab | N | Y | 220030717 | RITUXIMAB |
| 220013632 | 220008062 | 1.8 | 72.9 | Curative (C) | 2015-08-10 | 2015-08-14 | AML 18 TRIAL | Y | N | 220030719 | AML18 TRIAL |
| 220013633 | 220008063 | 1.77 | 101.4 | Palliative (P) | 2017-06-22 | 2017-06-22 | Dasatinib | N | null | 220030722 | DASATINIB |
| 220013634 | 220008064 | null | 97 | Curative (C) | 2015-07-22 | 2015-07-22 | Rituximab | 2 | N | 220030722 | RITUXIMAB |
| 220013635 | 220008064 | 1.79 | 74.2 | Curative (C) | 2017-10-06 | 2017-11-18 | AML 18 TRIAL | 1 | N | 220030722 | AML18 TRIAL |
| 220013636 | 220008064 | 1.6 | 66 | Curative (C) | 2016-07-27 | 2016-11-03 | AML18 PILOT TRIAL | Y | Y | 220030722 | PILOT TRIAL |
| 220013637 | 220008066 | 1.59 | 78.7 | Curative (C) | 2013-10-03 | 2013-10-03 | Dasatinib | 02 | N | 220030731 | DASATINIB |
| 220013638 | 220008067 | 1.88 | null | Curative (C) | 2013-04-29 | 2013-04-29 | ALEMTUZUMAB + FLUDARABINE + MELPHALAN | N | null | 220030733 | ALEMTUZUMAB + FLUDARABINE + MELPHALAN |
| 220013639 | 220008069 | 1.7 | 63 | Curative (C) | 2013-05-31 | 2013-06-11 | Alemtuz+Fludara+Melphalan RIC MUD | N | N | 220030735 | ALEMTUZUMAB + FLUDARABINE + MELPHALAN |
| 220013640 | 220008071 | 1.61 | null | Curative (C) | 2016-08-30 | 2016-09-14 | Rituximab | N | N | 220030736 | RITUXIMAB |
| 220013641 | 220017866 | null | 59.9 | Curative (C) | 2014-05-13 | 2014-06-17 | AML18 PILOT TRIAL | Y | null | 220030737 | PILOT TRIAL |
| 220013642 | 220008073 | 1.58 | 78.7 | Disease modification (D) | null | 2017-02-01 | Rituximab | N | null | 220030737 | RITUXIMAB |
| 220013643 | 220008075 | 1.66 | 100 | null | 2014-07-02 | 2014-07-13 | AML 18 TRIAL | Y | N | 220030740 | AML18 TRIAL |
| 220013644 | 220008076 | null | null | Disease modification (D) | 2014-03-22 | 2014-06-22 | Rituximab | N | N | 220030743 | RITUXIMAB |
| 220013645 | 220008079 | 1.63 | null | Curative (C) | 2013-10-27 | 2013-11-07 | ALEMTUZUMAB + FLUDARABINE + MELPHALAN | N | null | 220030748 | ALEMTUZUMAB + FLUDARABINE + MELPHALAN |
| 220013646 | 220008080 | null | null | Curative (C) | 2015-07-01 | 2015-07-01 | Rituximab | 02 | null | 220030753 | RITUXIMAB |
| 220013647 | 220008081 | 1.88 | 100.5 | null | 2014-07-16 | 2014-10-20 | AML 18 TRIAL | N | N | 220030754 | AML18 TRIAL |
| 220013648 | 220008084 | 0 | null | Curative (C) | 2017-07-14 | 2017-07-20 | Dasatinib | 2 | N | 220030759 | DASATINIB |
| 220013651 | 220008086 | 0 | 80.6 | Curative (C) | 2013-10-13 | 2013-10-13 | ALEMTUZUMAB + FLUDARABINE + MELPHALAN | 02 | N | 220030766 | ALEMTUZUMAB + FLUDARABINE + MELPHALAN |
| 220013652 | 220008089 | 1.63 | null | Curative (C) | 2017-04-07 | 2017-04-08 | Dasatinib | 2 | N | 220030766 | DASATINIB |
| 220013653 | 220008089 | 1.6 | 54.6 | Disease modification (D) | 2016-02-20 | 2016-07-14 | Alemtuz+Fludara+Melphalan RIC MUD | N | null | 220030766 | ALEMTUZUMAB + FLUDARABINE + MELPHALAN |
| 220013657 | 220008090 | 1.76 | 81 | null | 2016-03-03 | 2016-03-04 | Alemtuz+Fludara+Melphalan RIC MUD | N | N | 220030779 | ALEMTUZUMAB + FLUDARABINE + MELPHALAN |
| 220013658 | 220020925 | 0 | null | Palliative (P) | 2015-06-11 | 2015-06-15 | Dasatinib | N | N | 220030783 | DASATINIB |
| 220013659 | 220020925 | null | 58.6 | Curative (C) | null | 2017-06-10 | Rituximab | N | null | 220030783 | RITUXIMAB |
| 220013660 | 220008091 | 1.62 | 90.4 | Curative (C) | 2015-09-15 | 2015-09-24 | Alemtuz+Fludara+Melphalan RIC MUD | N | N | 220030784 | ALEMTUZUMAB + FLUDARABINE + MELPHALAN |
| 220013661 | 220008091 | 1.79 | 60.33 | null | 2013-06-23 | 2013-06-24 | Alemtuz+Fludara+Melphalan RIC MUD | 02 | N | 220030784 | ALEMTUZUMAB + FLUDARABINE + MELPHALAN |
| 220013662 | 220008091 | 1.64 | null | Curative (C) | 2014-12-25 | 2014-12-25 | Dasatinib | null | N | 220030784 | DASATINIB |
| 220013663 | 220008092 | null | 54.7 | Curative (C) | 2016-08-25 | 2016-08-25 | Alemtuz+Fludara+Melphalan RIC MUD | N | N | 220030801 | ALEMTUZUMAB + FLUDARABINE + MELPHALAN |
| 220013664 | 220008093 | 1.67 | 73.4 | Curative (C) | 2014-09-05 | 2014-09-17 | AML18 PILOT TRIAL | 01 | N | 220030802 | PILOT TRIAL |
| 220013665 | 220008094 | null | 0 | Adjuvant (A) | 2016-07-07 | 2016-07-09 | Rituximab | 02 | null | 220030802 | RITUXIMAB |
| 220013666 | 220008094 | 1.68 | 122 | Neo-adjuvant (N) | 2014-07-13 | 2015-06-12 | Rituximab | 2 | N | 220030802 | RITUXIMAB |
| 220013667 | 220008096 | 1.73 | null | Curative (C) | 2015-08-31 | 2015-09-03 | Alemtuz+Fludara+Melphalan RIC MUD | null | null | 220030808 | ALEMTUZUMAB + FLUDARABINE + MELPHALAN |
| 220013668 | 220008097 | 0 | 50 | null | 2017-07-25 | 2017-07-25 | Rituximab | N | N | 220030809 | RITUXIMAB |
| 220013670 | 220008100 | 1.79 | 91.1 | Curative (C) | 2017-01-13 | 2017-02-26 | AML 18 Pilot Trial | 01 | N | 220030811 | PILOT TRIAL |
| 220013671 | 220017871 | 1.69 | 81.3 | Curative (C) | 2016-05-24 | 2016-05-24 | Alemtuz+Fludara+Melphalan RIC MUD | N | N | 220030819 | ALEMTUZUMAB + FLUDARABINE + MELPHALAN |
| 220013672 | 220008101 | 0 | 74.4 | Curative (C) | 2014-12-09 | 2015-01-11 | ALEMTUZUMAB + FLUDARABINE + MELPHALAN | N | N | 220030820 | ALEMTUZUMAB + FLUDARABINE + MELPHALAN |
| 220013673 | 220008102 | 1.63 | 62 | Curative (C) | 2016-09-29 | 2016-11-23 | AML18 PILOT TRIAL | N | N | 220030822 | PILOT TRIAL |
| 220013674 | 220008102 | 1.67 | 71.2 | null | 2013-08-26 | 2013-08-27 | AML 18 TRIAL | Y | N | 220030822 | AML18 TRIAL |
| 220013675 | 220017872 | 1.55 | null | Adjuvant (A) | 2017-08-27 | 2017-11-12 | Dasatinib | N | N | 220030823 | DASATINIB |
| 220013676 | 220017872 | 1.59 | 59.7 | Curative (C) | 2017-09-23 | 2017-10-11 | Alemtuz+Fludara+Melphalan RIC MUD | N | null | 220030823 | ALEMTUZUMAB + FLUDARABINE + MELPHALAN |
| 220013677 | 220017872 | null | 80 | Curative (C) | 2014-04-04 | 2014-04-14 | ALEMTUZUMAB + FLUDARABINE + MELPHALAN | N | N | 220030823 | ALEMTUZUMAB + FLUDARABINE + MELPHALAN |
| 220013678 | 220008103 | 1.68 | 62.5 | Curative (C) | 2014-03-26 | 2014-05-11 | AML18 PILOT TRIAL | Y | N | 220030837 | PILOT TRIAL |
| 220013679 | 220008104 | 1.7 | 95 | Curative (C) | null | 2016-05-16 | Alemtuz+Fludara+Melphalan RIC MUD | N | null | 220030840 | ALEMTUZUMAB + FLUDARABINE + MELPHALAN |
| 220013680 | 220008106 | 1.84 | 76.5 | Curative (C) | 2018-01-03 | 2018-01-09 | Dasatinib | N | N | 220030842 | DASATINIB |
| 220013681 | 220008107 | 1.66 | 27.25 | Disease modification (D) | 2018-08-06 | 2018-08-06 | Rituximab | null | N | 220030847 | RITUXIMAB |
| 220013682 | 220008108 | 1.58 | 95.7 | Curative (C) | null | 2013-08-06 | AML18 PILOT TRIAL | Y | null | 220030849 | PILOT TRIAL |
| 220013683 | 220008111 | 1.61 | 83.3 | Curative (C) | 2017-09-07 | 2017-09-10 | Dasatinib | 02 | N | 220030858 | DASATINIB |
| 220013684 | 220008112 | 1.57 | 65.2 | Disease modification (D) | 2017-03-01 | 2017-06-10 | Dasatinib | 02 | N | 220030863 | DASATINIB |